Literature DB >> 25251500

Conformational flexibility tunes the propensity of transthyretin to form fibrils through non-native intermediate states.

Jitendra K Das1, Shyam S Mall, Aritra Bej, Sujoy Mukherjee.   

Abstract

The formation of partially unfolded intermediates through conformational excursions out of the native state is the starting point of many diseases involving protein aggregation. Therapeutic strategies often aim to stabilize the native structure and prevent the formation of intermediates that are also cytotoxic in vivo. However, their transient nature and low population makes it difficult to characterize these intermediates. We have probed the backbone dynamics of transthyretin (TTR) over an extended timescale by using NMR spectroscopy and MD simulations. The location and extent of these motions indicates that the backbone flexibility of TTR is a cause of dissociation and destabilization, both of which are responsible for fibril formation. Importantly, approximately 10 % of wild-type TTR exists in an intermediate state, which increased to up to 28 % for pathogenic TTR mutants, for which the formation of the intermediate state is shown to be energetically more favorable compared to the wild type. This result suggests an important role for the intermediates in TTR amyloidosis.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Amyloids; NMR spectroscopy; misfolding intermediates; protein folding; transthyretin

Mesh:

Substances:

Year:  2014        PMID: 25251500     DOI: 10.1002/anie.201407323

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  10 in total

1.  Pathogenic Mutations Induce Partial Structural Changes in the Native β-Sheet Structure of Transthyretin and Accelerate Aggregation.

Authors:  Kwang Hun Lim; Anvesh K R Dasari; Renze Ma; Ivan Hung; Zhehong Gan; Jeffery W Kelly; Michael C Fitzgerald
Journal:  Biochemistry       Date:  2017-08-30       Impact factor: 3.162

2.  FRET studies of various conformational states adopted by transthyretin.

Authors:  Seyyed Abolghasem Ghadami; Francesco Bemporad; Benedetta Maria Sala; Guido Tiana; Stefano Ricagno; Fabrizio Chiti
Journal:  Cell Mol Life Sci       Date:  2017-05-06       Impact factor: 9.261

3.  NMR Measurements Reveal the Structural Basis of Transthyretin Destabilization by Pathogenic Mutations.

Authors:  Benjamin I Leach; Xin Zhang; Jeffery W Kelly; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2018-07-18       Impact factor: 3.162

4.  Inherent conformational plasticity in dsRBDs enables interaction with topologically distinct RNAs.

Authors:  Harshad Paithankar; Guneet Singh Tarang; Firdousi Parvez; Aniket Marathe; Manali Joshi; Jeetender Chugh
Journal:  Biophys J       Date:  2022-02-05       Impact factor: 4.033

5.  Structural Changes Associated with Transthyretin Misfolding and Amyloid Formation Revealed by Solution and Solid-State NMR.

Authors:  Kwang Hun Lim; Anvesh K R Dasari; Ivan Hung; Zhehong Gan; Jeffery W Kelly; David E Wemmer
Journal:  Biochemistry       Date:  2016-03-23       Impact factor: 3.162

Review 6.  Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism.

Authors:  Jin-Beom Si; Bokyung Kim; Jin Hae Kim
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

7.  Skeletal Muscle Dystrophy mutant of lamin A alters the structure and dynamics of the Ig fold domain.

Authors:  Subarna Dutta; Jitendra K Das; Lakshmi Maganti; Maitree Bhattacharyya; Dhananjay Bhattacharyya; Sujoy Mukherjee; Kaushik Sengupta
Journal:  Sci Rep       Date:  2018-09-14       Impact factor: 4.379

8.  Molecular dynamics simulation study of AG10 and tafamidis binding to the Val122Ile transthyretin variant.

Authors:  Kevin F Morris; Riley M Geoghegan; Emily E Palmer; Matthew George; Yayin Fang
Journal:  Biochem Biophys Rep       Date:  2020-01-17

9.  Exploration of the Misfolding Mechanism of Transthyretin Monomer: Insights from Hybrid-Resolution Simulations and Markov State Model Analysis.

Authors:  Shuangyan Zhou; Jie Cheng; Ting Yang; Mingyue Ma; Wenying Zhang; Shuai Yuan; Glenn V Lo; Yusheng Dou
Journal:  Biomolecules       Date:  2019-12-17

10.  Diphenyl-Methane Based Thyromimetic Inhibitors for Transthyretin Amyloidosis.

Authors:  Bokyung Kim; Young Ho Ko; Massimiliano Runfola; Simona Rapposelli; Gabriella Ortore; Grazia Chiellini; Jin Hae Kim
Journal:  Int J Mol Sci       Date:  2021-03-28       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.